CLINICAL_TRIALS trial_result · 2022-04-04

Clinical Trial Update: Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) [Phase 3]

Phase 3 trial of ITAC, an anti-coronavirus immunoglobulin, for inpatient treatment of COVID-19 has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Minnesota | Conditions: COVID, COVID-19 | Phase 3 | Status: COMPLETED | Results posted: 2022-04-04